Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, representing approximately 85% of all lung cancer cases. As the demand for effective treatments continues to rise, the NSCLC treatment market is experiencing substantial growth. This blog provides a detailed analysis of the market size, growth projections, competitive landscape, and other critical […]